SMTL ID : 6f2u.1

Potent and selective Aldo-Keto Reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety: application of a Bioisosteric Scaffold Hopping Approach to Flufenamic acid

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.88 Å

Oligo State

homo-dimer

Ligands

2 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)

NAP.1: 28 residues within 4Å: Chain A: G.17, T.18, Y.19, D.45, Y.50, H.112, S.161, N.162, Q.185, Y.211, S.212, A.213, L.214, G.215, S.216, Q.217, L.231, A.248, L.263, A.264, K.265, S.266, Y.267, N.268, R.271, Q.274, N.275 Ligands: CJ2.2 26 PLIP interactions: 26 interactions with chain A Hydrogen bonds: A:T.18, A:Y.19, A:D.45, A:D.45, A:Y.50, A:S.161, A:N.162, A:Q.185, A:S.212, A:S.212, A:L.214, A:G.215, A:S.216, A:Q.217, A:K.265, A:S.266, A:Y.267, A:Q.274, A:N.275 Water bridges: A:A.213, A:Q.217, A:Q.217 Salt bridges: A:K.265, A:R.271 pi-Stacking: A:Y.211 pi-Cation interactions: A:R.271 NAP.3: 28 residues within 4Å: Chain B: G.17, T.18, Y.19, D.45, Y.50, K.79, H.112, S.161, N.162, Q.185, Y.211, S.212, A.213, L.214, G.215, S.216, Q.217, L.231, A.248, L.263, A.264, K.265, S.266, Y.267, R.271, Q.274, N.275 Ligands: CJ2.4 26 PLIP interactions: 26 interactions with chain B Hydrogen bonds: B:T.18, B:Y.19, B:D.45, B:S.161, B:N.162, B:Q.185, B:S.212, B:S.212, B:L.214, B:G.215, B:S.216, B:Q.217, B:K.265, B:S.266, B:Y.267, B:Q.274, B:N.275 Water bridges: B:A.213, B:A.213, B:Q.217, B:Q.217, B:T.246 Salt bridges: B:K.265, B:R.271 pi-Stacking: B:Y.211 pi-Cation interactions: B:R.271

2 x CJ2: 3-[(4-methoxyphenyl)methyl]-5-oxidanyl-~{N}-[3-(trifluoromethyl)phenyl]-1,2,3-triazole-4-carboxamide(Non-covalent)

CJ2.2: 16 residues within 4Å: Chain A: Y.19, L.49, Y.50, W.81, H.112, S.113, N.162, E.187, Y.211, S.212, S.216, W.222, Y.300, F.301, P.313 Ligands: NAP.1 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:W.81, A:W.81, A:F.301, A:F.301 Hydrogen bonds: A:H.112, A:S.212 CJ2.4: 16 residues within 4Å: Chain B: Y.19, L.49, Y.50, W.81, H.112, S.113, M.115, N.162, E.187, Y.211, S.212, S.216, W.222, Y.300, F.301 Ligands: NAP.3 7 PLIP interactions: 7 interactions with chain B Hydrophobic interactions: B:W.81, B:W.81, B:F.301 Hydrogen bonds: B:Y.50, B:H.112, B:S.212 Water bridges: B:E.187

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Pippione, A.C. et al., Potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety: application of a bioisosteric scaffold hopping approach to flufenamic acid. Eur J Med Chem (2018)

Release Date

2018-04-04

Peptides

Aldo-keto reductase family 1 member C3: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Aldo-keto reductase family 1 member C3